| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-05 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-05 |
| mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |